Harvoni and Ibrance drug interactions - a phase IV clinical study of FDA data
Summary:
We study 124,291 people who take Harvoni (ledipasvir; sofosbuvir) and Ibrance (palbociclib). There is no drug interaction reported.
The study analyzes what interactions people have when they take Harvoni and Ibrance. It is created by eHealthMe based on reports the from the FDA, and is updated regularly.
What is Harvoni?
Harvoni has active ingredients of ledipasvir; sofosbuvir. eHealthMe is studying from 19,858 Harvoni users. Check the latest studies of Harvoni.
What is Ibrance?
Ibrance has active ingredients of palbociclib. eHealthMe is studying from 104,433 Ibrance users. Check the latest studies of Ibrance.
No report is found.
Do you take Harvoni and Ibrance?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
How the study uses the data?
The study uses data from the FDA. It is based on ledipasvir; sofosbuvir and palbociclib (the active ingredients of Harvoni and Ibrance, respectively), and Harvoni and Ibrance (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Regular Insulin cause Hepatic Cirrhosis? - 2 seconds ago
- Drug interactions of Revatio and Sertraline - 2 seconds ago
- Drug interactions of Darzalex and Clopidogrel - 8 seconds ago
- Could Fludara cause Acute Graft Versus Host Disease In Skin? - 9 seconds ago
- Could Phenergan cause Peptic Ulcer Aggravated? - 9 seconds ago
- Twynsta and Fast Heart Rate for Men aged 60+ - 14 seconds ago
- Twynsta and Rapid Heart Beat for Men aged 60+ - 14 seconds ago
- Twynsta and Heart Rate Increased for Men aged 60+ - 15 seconds ago
- Albuterol Sulfate and Pleuritis for Women aged 60+ - 18 seconds ago
- Albuterol Sulfate and Pleuritic Chest Pain for Women aged 60+ - 19 seconds ago